Money, morality drive stem cell ballot debate
The Record Thu, 01 Nov 2007 9:59 PM PDT
A Nov. 6 ballot question about whether the state should borrow $450 million for stem cell research has New Jerseyans sharply divided over issues of life and money. |
Poll: NJ Stem Cell Support Varies
AP via Yahoo! Finance Thu, 01 Nov 2007 10:13 AM PDT
New Jersey voters appear ready to support borrowing $450 million for stem cell research, but a poll released Thursday found the outcome could depend on who shows up to vote next week. |
Seniors push stem cell research
Tuscaloosa News Thu, 01 Nov 2007 10:09 AM PDT
MONTGOMERY | A Montgomery woman who said she recovered from significant heart problems with the help of adult stem cell research on Wednesday endorsed a resolution by the Silver-Haired Legislature calling on the state to fund the research. |
Cytori Receives European Approval for 2nd Generation Celution(TM) Stem & Regenerative Cell Processing System
Business Wire via Yahoo!7 Finance Thu, 01 Nov 2007 5:00 AM PDT
Cytori Therapeutics, Inc. (NASDAQ:CYTX) received European approval - CE Mark - for the second generation Celution(TM) stem and regenerative cell processing system. The Celution(TM) System is the only device approved in Europe to extract and concentrate a patient's own stem and regenerative cells from within fat tissue in order to be delivered back to the same patient in the same procedure. |
Corzine puts own money into stem cell measure
The Record Thu, 01 Nov 2007 2:32 AM PDT
Governor Corzine has dipped into his own deep pockets to urge New Jersey voters to approve a plan to borrow $450 million for stem cell research. Corzine, a multimillionaire, has given $150,000 to New Jersey for Hope, a recently formed political committee, to run ads supporting the initiative. |
Stem cell cash vow
Herald Sun Thu, 01 Nov 2007 6:00 AM PDT
MONASH University has vowed to return the taxpayer funds spent on Prof Alan Trounson's abandoned stem cell research if it finds problems with the project. |
Reassuring News For Muscular Dystrophy And Heart Disease Patients Following Gene, Stem Cell Therapy
Medical News Today Thu, 01 Nov 2007 7:18 AM PDT
Heart disease is the leading cause of death in the United States and greatly affects the quality and length of life for individuals with specific forms of muscular dystrophy. Recent discoveries have demonstrated that gene and/or stem cell therapy could help a variety of organs in the body, but until now scientists have been unsure whether the heart could benefit from these treatments. [click ... |
Dutch Stem-Cell Bank Cryo-Save To List On London's AIM
Nasdaq Thu, 01 Nov 2007 0:24 AM PDT
LONDON -(Dow Jones)- Cryo-Save Group NV, a Dutch-based adult stem-cell storage bank, Thursday said it will list on London's Alternative Investment Market with a market capitalization of around GBP101 million. |
Groundbreaking Researcher Joins Yale Stem Cell Center
Medical News Today Thu, 01 Nov 2007 4:03 AM PDT
Natalia Ivanova, a young scientist who has already made landmark contributions to stem cell research, will join the Yale School of Medicine Stem Cell Center as assistant professor of genetics and the first Robert McCluskey Yale Scholar. Ivanova comes to Yale from Princeton University, where she was a research scholar in the Department of Molecular Biology. [click link for full article] |
| |
|
